Literature DB >> 12829248

Control of glycogen deposition.

Juan C Ferrer1, Cristián Favre, Roger R Gomis, Josep M Fernández-Novell, Mar García-Rocha, Núria de la Iglesia, Emili Cid, Joan J Guinovart.   

Abstract

Traditionally, glycogen synthase (GS) has been considered to catalyze the key step of glycogen synthesis and to exercise most of the control over this metabolic pathway. However, recent advances have shown that other factors must be considered. Moreover, the control of glycogen deposition does not follow identical mechanisms in muscle and liver. Glucose must be phosphorylated to promote activation of GS. Glucose-6-phosphate (Glc-6-P) binds to GS, causing the allosteric activation of the enzyme probably through a conformational rearrangement that simultaneously converts it into a better substrate for protein phosphatases, which can then lead to the covalent activation of GS. The potency of Glc-6-P for activation of liver GS is determined by its source, since Glc-6-P arising from the catalytic action of glucokinase (GK) is much more effective in mediating the activation of the enzyme than the same metabolite produced by hexokinase I (HK I). As a result, hepatic glycogen deposition from glucose is subject to a system of control in which the 'controller', GS, is in turn controlled by GK. In contrast, in skeletal muscle, the control of glycogen synthesis is shared between glucose transport and GS. The characteristics of the two pairs of isoenzymes, liver GS/GK and muscle GS/HK I, and the relationships that they establish are tailored to suit specific metabolic roles of the tissues in which they are expressed. The key enzymes in glycogen metabolism change their intracellular localization in response to glucose. The changes in the intracellular distribution of liver GS and GK triggered by glucose correlate with stimulation of glycogen synthesis. The translocation of GS, which constitutes an additional mechanism of control, causes the orderly deposition of hepatic glycogen and probably represents a functional advantage in the metabolism of the polysaccharide.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829248     DOI: 10.1016/s0014-5793(03)00565-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  49 in total

1.  Nutrient selection in the absence of taste receptor signaling.

Authors:  Xueying Ren; Jozélia G Ferreira; Ligang Zhou; Sara J Shammah-Lagnado; Catherine W Yeckel; Ivan E de Araujo
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

2.  Effects of dietary methionine restriction on postnatal growth, insulin sensitivity, and glucose metabolism in intrauterine growth retardation pigs at 49 and 105 d of age.

Authors:  Zhixiong Ying; Xiaoke Ge; Hao Zhang; Weipeng Su; Yue Li; Le Zhou; Lili Zhang; Tian Wang
Journal:  J Anim Sci       Date:  2019-02-01       Impact factor: 3.159

3.  Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth.

Authors:  Xiaocheng Dong; Sunmin Park; Xueying Lin; Kyle Copps; Xianjin Yi; Morris F White
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

4.  The control of hepatic glycogen metabolism in an in vitro model of sepsis.

Authors:  Jennifer Wallington; Jian Ning; Michael Alan Titheradge
Journal:  Mol Cell Biochem       Date:  2007-10-13       Impact factor: 3.396

5.  Unclassified polysaccharidosis of the heart and skeletal muscle in siblings.

Authors:  Benedikt Schoser; Claudio Bruno; Hans-Christian Schneider; Yoon S Shin; Teodor Podskarbi; Lev Goldfarb; Wolfgang Müller-Felber; Josef Müller-Höcker
Journal:  Mol Genet Metab       Date:  2008-08-08       Impact factor: 4.797

6.  CLOCK regulates circadian rhythms of hepatic glycogen synthesis through transcriptional activation of Gys2.

Authors:  Ryosuke Doi; Katsutaka Oishi; Norio Ishida
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

7.  Acute paraquat exposure determines dose-dependent oxidative injury of multiple organs and metabolic dysfunction in rats: impact on exercise tolerance.

Authors:  Rômulo D Novaes; Reggiani V Gonçalves; Marli C Cupertino; Eliziária C Santos; Solange M Bigonha; Geraldo J M Fernandes; Izabel R S C Maldonado; Antônio J Natali
Journal:  Int J Exp Pathol       Date:  2016-06-09       Impact factor: 1.925

8.  AMP-activated protein kinase phosphorylates R5/PTG, the glycogen targeting subunit of the R5/PTG-protein phosphatase 1 holoenzyme, and accelerates its down-regulation by the laforin-malin complex.

Authors:  Santiago Vernia; M Carmen Solaz-Fuster; José Vicente Gimeno-Alcañiz; Teresa Rubio; Luisa García-Haro; Marc Foretz; Santiago Rodríguez de Córdoba; Pascual Sanz
Journal:  J Biol Chem       Date:  2009-01-26       Impact factor: 5.157

9.  Characterization of the Antidiabetic Role of Parkinsonia aculeata (Caesalpineaceae).

Authors:  Ana Catarina Rezende Leite; Tiago Gomes Araújo; Bruno de Melo Carvalho; Maria Bernadete Souza Maia; Vera Lúcia de Menezes Lima
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-19       Impact factor: 2.629

10.  An integrated functional genomic study of acute phenobarbital exposure in the rat.

Authors:  Claire L Waterman; Richard A Currie; Lisa A Cottrell; Jacky Dow; Jayne Wright; Catherine J Waterfield; Julian L Griffin
Journal:  BMC Genomics       Date:  2010-01-06       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.